Masashi Ukai
Tsukuba, 3058585, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
A non-interventional cross-sectional re-contact study investigating the relationship between overactive bladder and frailty in older adults in Japan.
Journal: BMC geriatrics
Published: August 06, 2021
Efficacy of mirabegron, a β3 -adrenoreceptor agonist, in Japanese women with overactive bladder and either urgency urinary incontinence or mixed urinary incontinence: Post-hoc analysis of pooled data from two randomized, placebo-controlled, double-blind studies.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: April 28, 2021
Effect of ASP2205 fumarate, a novel 5-HT2C receptor agonist, on urethral closure function in rats.
Journal: Journal of pharmacological sciences
Published: January 15, 2019
Contribution of pharmacological research to the discovery of a first-in-class drug, mirabegron, for the treatment of overactive bladder
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: September 07, 2018
Translational science approach for assessment of cardiovascular effects and proarrhythmogenic potential of the beta-3 adrenergic agonist mirabegron.
Journal: Journal of pharmacological and toxicological methods
Published: November 04, 2016
Pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in cynomolgus monkeys.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: April 19, 2013
In vitro and in vivo pharmacological profile of the selective β3-adrenoceptor agonist mirabegron in rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: October 25, 2012
Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: August 10, 2012
Pharmacological and clinical profile of mirabegron (Betanis(®)): a new therapeutic agent for overactive bladder
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Published: June 13, 2012
Tamsulosin potently and selectively antagonizes human recombinant α(1A/1D)-adrenoceptors: slow dissociation from the α(1A)-adrenoceptor may account for selectivity for α(1A)-adrenoceptor over α(1B)-adrenoceptor subtype.
Journal: Biological & pharmaceutical bulletin
Published: January 07, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026